An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation by Perkins Kenneth A, Lerman Caryn in Psychopharmacology (2013).

[PMID: 24297304] PubMed


Initial screening of new medications for potential efficacy (i.e., Food and Drug Administration (FDA) early phase 2), such as in aiding smoking cessation, should be efficient in identifying which drugs do, or do not, warrant more extensive (and expensive) clinical testing.

[ hide abstract ]

Discussed In Paper


Dosing Information

No dosing information annotated.